MK-677 (Ibutamoren): Dosage, Protocol, and Research Guide
Oral growth hormone secretagogue that increases GH and IGF-1 levels
Mechanism
Mimics ghrelin, binding to GHSR to stimulate growth hormone release from the pituitary gland
Protocol at a glance
| Starting dose | 10mg |
|---|---|
| Maintenance dose | 20-25mg |
| Maximum dose | 25mg |
| Frequency | Daily |
| Typical duration | 8-16 weeks |
| Route | Oral |
| Injection site | N/A |
| Timing | Before bed |
Side effects
- Increased appetite
- Water retention
- Mild lethargy
- Elevated blood sugar
Contraindications
- Diabetes
- Cancer history
- Severe cardiac conditions
Protocol notes
- Increases GH and IGF-1 without affecting cortisol
- Improves sleep quality
- May increase bone density
- Monitor glucose levels
- 24-hour half-life allows once-daily dosing
Frequently asked questions
What is MK-677 (Ibutamoren) used for?
MK-677 (Ibutamoren) has been studied for: Oral growth hormone secretagogue that increases GH and IGF-1 levels Mechanism: Mimics ghrelin, binding to GHSR to stimulate growth hormone release from the pituitary gland. For research purposes only — consult a licensed physician before use.
What is the standard MK-677 (Ibutamoren) dose?
Starting dose in published protocols is typically 10mg, titrating up to a maintenance dose of 20-25mg (max 25mg). Frequency: Daily. Route: Oral. Always confirm with a medical professional.
How is MK-677 (Ibutamoren) administered?
MK-677 (Ibutamoren) is typically administered oral at the n/a. Timing: Before bed. Rotate injection sites to avoid tissue irritation.
What are the side effects of MK-677 (Ibutamoren)?
Reported side effects include: Increased appetite, Water retention, Mild lethargy, Elevated blood sugar. Individual responses vary. Contact a healthcare provider if you experience unexpected symptoms.
Who should not take MK-677 (Ibutamoren)?
Contraindications in published research include: Diabetes, Cancer history, Severe cardiac conditions. This is not an exhaustive list — consult a physician before starting any peptide protocol.
How long does MK-677 (Ibutamoren) take to work?
Timelines vary by individual and goal. Published protocols run for 8-16 weeks. Track doses, side effects, and biomarker changes over time to measure your own response rather than relying on community averages.
How do I track MK-677 (Ibutamoren) with Alethea Health?
Alethea Health lets you log every MK-677 (Ibutamoren) dose, track adherence, sync wearable data (HRV, RHR, sleep), upload lab panels, and correlate changes to your protocol. Free to start — no credit card required.
More Growth Hormone Peptides peptides · All peptide guides · Free dose calculator
Educational reference only — not medical advice. Work with a qualified clinician.